Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Ozempic, Novo Nordisk
Ozempic’s Price ‘Very Likely’ To Be Subject Of Medicare Negotiations, Report Says
President Joe Biden’s Inflation Reduction Act allows Medicare to negotiate costly drug prices with pharmaceutical companies.
Ozempic ‘Very Likely’ to Face Drug Price Negotiations, Novo Says
Ozempic, the blockbuster diabetes shot made by Novo Nordisk A/S, is “very likely” to be one of the next drugs to have its price slashed in bargaining with the US government, a company executive said.
Novo Nordisk says Ozempic a “very likely” target in next Medicare drug pricing talks
A top executive at Novo Nordisk (NVO) warned Tuesday that the company’s diabetes therapy Ozempic will likely be selected for the next round of Medicare drug pricing negotiations, which aim to seek discounts for blockbuster meds supplied to the federal healthcare program.
Ozempic ‘very likely’ to see prices slashed in drug price negotiations
The ability to negotiate drug prices is part of a sweeping set of policies in President Joe Biden’s Inflation Reduction Act.
Novo Nordisk shares sink on medicare price negotiation fears
Jared Holz, Mizuho, joins 'Fast Money' to talk how possible Medicare price negotiations are impacting Novo Nordisk shares.
Bernie Sanders, Ozempic
Bernie Sanders says Ozempic can be produced for less than $100 a month
Sen. Sanders claims that the CEOs of major generic drugmakers said they produce and sell Ozempic for less $100 a month.
Sanders announces generic pharma companies willing to sell Ozempic for less than $100
Chairman of the Senate Health, Education, Labor, and Pensions Committee (HELP), today announced that CEOs of major generic pharmaceutical companies are willing to sell Ozempic to Americans for less than $100 per month at a profit.
US Senator Sanders Says Generic Drugmakers Could Sell Ozempic for Less Than $100/month
U.S. Senator Bernie Sanders said on Tuesday he received confirmation from major generic pharmaceutical companies that they could sell copycat versions of Novo Nordisk's diabetes drug Ozempic for less than $100 a month.
JD Supra
1h
Ozempic Lawsuit Update: New Study Links Semaglutides to Increased Risk of Vision Loss
More plaintiffs are continuing to join the diabetes drug Ozempic lawsuits against Novo Nordisk; and, until a couple of weeks ...
6d
Novo Nordisk’s New Obesity Pill Beats Wegovy In Early Trial
Data from an early stage clinical trial suggests Novo Nordisk’s new weight loss pill amycretin could produce greater and more ...
MarketWatch
1h
Health Care Down as Novo Nordisk Slides on Drug-Price Fears - Health Care Roundup
Health-care companies fell amid fears of pharmaceutical drug-price controls.
Novo
Nordisk
's
Ozempic
is "very likely" to be one the next drugs to have its price slashed in bargaining with the U.S ...
Vermont Business Magazine
1d
Ahead of Novo Nordisk hearing, 250 clinicians demand affordable access to Ozempic and Wegovy
Novo Nordisk CEO Lars Jørgensen will testify about the high cost of Ozempic and Wegovy at an upcoming HELP Committee hearing on September 24th.
7d
Ozempic maker touts ‘remarkable,’ ‘more convenient’ new pill that promises to help you shed up to 13% of your weight in 3 months
Ozempic maker Novo Nordisk has developed a pill that can cause weight loss of up to 13% in three months, according to new ...
Futurism on MSN
2d
Doctors Concerned About Drugmakers Testing Ozempic-Style Injections on Six-Year-Olds
With so many kids already taking weight loss injectables like Ozempic, a new finding from the company behind the blockbuster ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Related topics
Wegovy
Bernie Sanders
Amycretin
Phases of clinical research
Feedback